Intralesional 5-fluorouracil in the treatment of keloid scars.
Two patients with keloid scars are described. The first patient presented with extensive keloid scarring on both cheeks secondary to acne. The second patient developed a keloid scar on her chest following excision of a mole. Both patients' scars were diagnosed clinically and treated with fortnightly injections of a mixture of 5-fluorouracil and betamethasone acetate and betamethasone sodium phosphate. At each injection session up to 1.6 mL of 5-fluorouracil at a concentration of 500 mg/10 mL and 0.4 mL of betamethasone acetate and betamethasone sodium phosphate (as betamethasone acetate 3 mg in suspension and betamethasone sodium phosphate 3.9 mg in solution) were used. Multiple treatments were required to obtain resolution of the keloid scars. Improvement was maintained in both patients at 1 year post treatment.
Apikian
Martine
M
Specialist Cosmetic Laser Clinic, 8th Floor, Trak Centre, 445 Toorak Road, Toorak 5142, Melbourne, Victoria, Australia. greggoodman@greggoodman.com.au
Goodman
Greg
G
D000153:Acne Keloid / Q000188:drug therapy; D000328:Adult; D000963:Antimetabolites / Q000008:administration & dosage / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015552:Injections, Intralesional; D007627:Keloid / Q000188:drug therapy*; D008297:Male; D013909:Thorax
D000963:Antimetabolites; D005938:Glucocorticoids; C028994:betamethasone sodium phosphate; D001623:Betamethasone; D005472:Fluorouracil